SCHEMBL24334337

SCHEMBL24334337

Cc1ccc2cccc(S(=O)(=O)NC(=O)c3cc4c(F)cc(N5CCC5(C)C)cc4o3)c2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.39
TSHR P16473 3/20 0.39
USP2 O75604 2/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.37
TP53 P04637 3/20 0.37
KDM4E B2RXH2 1/20 0.37
HSD17B10 Q99714 2/20 0.34
PKLR P30613 3/20 0.33
NFKBIA P25963 1/20 0.33
RELA Q04206 1/20 0.33
SLC40A1 Q9NP59 1/20 0.33
CRHBP P24387 1/20 0.32
MAPK1 P28482 1/20 0.32
CRHR2 Q13324 1/20 0.32
THRB P10828 2/20 0.32
LDHA P00338 1/20 0.32
ABCB1 P08183 1/20 0.32
ABCC1 P33527 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29469662 1.00 POLB (0.39) POLBTSHRUSP2LMNASMN1; SMN2
SCHEMBL24334001 0.89 POLB (0.42) POLBTSHRUSP2LMNASMN1; SMN2
SCHEMBL29469820 0.89 POLB (0.42) POLBTSHRUSP2LMNASMN1; SMN2
SCHEMBL29469614 0.84 POLB (0.39) POLBTSHRUSP2LMNASMN1; SMN2
SCHEMBL24334348 0.84 POLB (0.39) POLBTSHRUSP2LMNASMN1; SMN2
SCHEMBL24333584 0.84 POLB (0.40) POLBTSHRUSP2LMNASMN1; SMN2
SCHEMBL29469615 0.84 POLB (0.40) POLBTSHRUSP2LMNASMN1; SMN2
SCHEMBL24334341 0.83 ALDH1A1 (0.38) POLBTSHRUSP2LMNATP53
SCHEMBL24333785 0.83 POLB (0.38) POLBTSHRUSP2LMNASMN1; SMN2
SCHEMBL29469712 0.83 POLB (0.38) POLBTSHRUSP2LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed